Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(2S,5S,8S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S,44S,50S)-50-amino-5,14,35,38-tetrakis(4-aminobutyl)-8,41-dibenzyl-20-sec-butyl-26-(3-guanidinopropyl)-2,17,23,29,32,44-hexaisobutyl-52-methyl-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49-hexadecaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48-hexadecaazatripentacontan-1-oic acid
ID: ALA5288505
Chembl Id: CHEMBL5288505
Max Phase: Preclinical
Molecular Formula: C100H174N24O18
Molecular Weight: 2000.64
Associated Items: